Counselors in Kosciusko, MS Accepting Medicare
7 Counselors found. Showing 1 - 7
 Eunice Denise Bennamon Counselor Medicare: Not Enrolled in Medicare Practice Location: 315 N Madison St, Kosciusko, MS 39090 Phone: 662-516-8668 |
Robin Bryant Pee, LPC-S Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 400 E Adams St Ofc A, Kosciusko, MS 39090 Phone: 662-582-0126 |
Annatrice Pringle Counselor Medicare: Not Enrolled in Medicare Practice Location: 315 N Madison St, Kosciusko, MS 39090 Phone: 662-516-8668 |
Mary Margaret Rawson, P-LPC, NCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 400 E Adams St Ofc A, Kosciusko, MS 39090 Phone: 662-571-6020 |
Allison Roach Counselor Medicare: Not Enrolled in Medicare Practice Location: 315 N Madison St, Kosciusko, MS 39090 Phone: 662-516-8668 Fax: 662-516-8676 |
Miss Valerie Michelle Mitchell, LMSW Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 332 Highway 12 W, Kosciusko, MS 39090 Phone: 662-289-1800 Fax: 662-289-9770 |
Elizabeth Louise Rhea Counselor Medicare: Not Enrolled in Medicare Practice Location: 217 N Madison St, Suite G, Kosciusko, MS 39090 Phone: 662-528-6187 |
News Archive
Effective medical communication missing between physicians and patients with chronic migraine
Many patients with chronic migraine (CM) receive suboptimal medical treatment even when they seek medical care. Reporting at the annual scientific meeting of the American Headache Society, researchers found that the majority of clinical encounters between CM patients and physicians were missing essential components of effective communication.
New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics
Sirna Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Sirna U.S. Patent No. 6,989,442 for the chemical synthesis and manufacturing of ribonucleic acids (RNA).
GIS scientists' zebrafish model may aid drug development for PD
Scientists at the Genome Institute of Singapore, a biomedical research institute of the Agency for Science, Technology and Research, have recently developed a zebrafish model for Parkinson's disease that can be used for understanding the mechanism underlying its development. The knowledge gained will be helpful for future screening of new drugs to treat Parkinson's disease.
Nasal antiviral blocks SARS-CoV-2 transmission in ferrets
A nasal antiviral created by researchers at Columbia University Vagelos College of Physicians and Surgeons blocked transmission of SARS-CoV-2 in ferrets, suggesting the nasal spray also may prevent infection in people exposed to the new coronavirus, including recent variants.
› Verified 3 days ago
Occupational Therapists
Pharmacists
Counselors
Dentists
Clinical Social Workers